Surgeons at Allegheny Health Network (AHN) Orthopaedic Institute embraced robotic technology for arthroplasty early on and use it to provide patients with the best possible care.
Allegheny Health Network
Latest Content
AHN's AI-ILD clinic provides collaborative care, uniting pulmonology and rheumatology specialists for efficient treatment of ILD.
AHN's urogynecology program offers comprehensive care for pelvic floor disorders, breaking barriers with tailored treatment plans for women's health.
The AccuCinch® System, utilized by Allegheny General Hospital, offers a breakthrough approach to treating heart failure by targeting the left ventricle.
Less invasive same-day surgery is an option for certain degenerative spine conditions, helping the patient recover more quickly and in a more comfortable home environment.
New clinic provides comprehensive hyperlipidemia services for patients.
A discussion with Briana DiSilvio, MD, a specialist in pulmonary and critical care at Allegheny Health Network
At West Penn Hospital, the harmonica program, currently in the pilot phase, aims to demonstrate its benefits in improving respiratory symptoms, reducing exacerbations, and enhancing patients' quality of life.
"Playing the harmonica has a therapeutic effect because of the pursed lip breathing technique it requires," Dr. Becky Jordan says in an interview.
Pelvic floor disorders affect nearly one in four women. Nonsurgical and advanced urogynecology treatments can offer women lasting relief.
A novel device has the potential to improve cardiac imaging for thousands of patients. The new technology, HeartFlow®, has advanced cardiac mapping capabilities. It provides 3D images of the coronary arteries without the need for invasive cardiac catheterization. The cardiovascular team at Allegheny Health Network has helped pioneer this advanced technology, dating back to its pilot study in 2016. Cleared by the FDA, HeartFlow® is another leading-edge option to provide high-quality cardiac care as efficiently and safely as possible.
Dr. Matthew Lander explains that the number of cardiac sarcoidosis cases might be lower than other forms of sarcoidosis, but the outcomes are more severe.
According to older literature, most cases of sarcoidosis involve the lungs, but Dr. Matthew Lander explains why there could be more to the rare disease.
PET scanning, in particular, has provided advancement in the diagnosis process, which has offered a new perspective on cardiac sarcoidosis for clinicians.
"Especially when untreated and in late stages of progression, ILD is well known to impact health related quality of life," according to Dr. Briana DiSilvio. "Chronic dyspnea, cough, and reduced exercise capacity can become disabling."
Dr. Thosani discusses the convergence of technology and physiology, treatment advancements, and virtual medicine capabilities in the field of heart arrhythmia.
The goal for many is to eradicate HCV by the year 2030.
Patients with obesity are at an increased risk of a number of diseases, including type 2 diabetes, IBD, and cardiovascular disease.
Dr. Raina describes the manifestations of pulmonary hypertension, CTEPH, and various treatment options available for the often underlooked condition.
Dr. Rindos emphasizes the importance of referring patients to an OBGYN if they're experiencing heavy bleeding or painful cramping.
Dr. Rindos discusses the intricacies of diagnosing and treating uterine fibroids, which develop in the majority of women.
Dr. Gadani often suggests patients eat smaller meals and do not eat too close to bedtime.
Dr. Akash B. Gadani said overall treatments for managing GERD are effective.
Maternal-fetal medicine specialist Dr. Michael Aziz shines a light on the leading complications for pregnant patients and why the US has the highest maternal mortality rate.
A continued discussion into misconceptions surrounding obesity treatments and how to better empower patients seeking out treatment.
A discussion into available pharmacotherapy for obesity and the uptake in practice of newer agents.
Dr. Christine Rauscher details immunotherapy for seasonal allergies, which affect roughly 20 millions adults in the US